Utilization of intravenous immunoglobulin therapy to treat recurrent pregnancy loss in the antiphospholipid syndrome: A review

Scandinavian Journal of Rheumatology, Supplement

Volumn 27, Issue 107, 1998, Pages 97-102

  Harris, E N ^a   Pierangeli, S S ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; IMMUNOGLOBULIN; PHOSPHOLIPID ANTIBODY; PREDNISONE;

ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; CONFERENCE PAPER; FEMALE; FETUS DISEASE; HUMAN; IMMUNOTHERAPY; INTRAUTERINE GROWTH RETARDATION; INTRAVENOUS DRUG ADMINISTRATION; PREECLAMPSIA; PREMATURITY; PRIORITY JOURNAL; RECURRENT ABORTION; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOSIS; IMMUNOLOGY; PREGNANCY; RECURRENT DISEASE; REVIEW;

ABORTION, HABITUAL; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PREGNANCY; RECURRENCE;

EID: 0031604952     PISSN: 03013847     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009742.1998.11720777     Document Type: Conference Paper

References (33)

1. Harris EN. Maternal autoantibodies and pregnancy. In: The Antiphospholipid Syndrome Bailliere's Clinical Rheumatology 1990; 4:53-68.
2. Harris EN. Syndrome of the Black Swan. Br J Rheumatol 1987; 26:324-6.
3. Nilsson IM, Astedt B, Hedner V, and Berezin D. Intra-uterine death and circulating anticoagulant ("anti-thromboplastin"). Acta Medica Scandinavica 1975; 197:153-9.
4. Soulier JP, and Boffa MC. Avortments a répétition thrombosis et anticoagulant circulant antithromboplastin. Nouv. Press. Medical. 1980; 9:859-64.
5. Carreras LO, Machin SJ, Deman R et al. Arterial thrombosis, intrauterine death and lupus anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981; i:244-6.
6. Hughes GRV. Thrombosis, abortion, cerebral lupus and lupus anticoagulant. Br Med J 1983; 287:1088-9.
7. Harris EN, Gharavi AE, Boey ML, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; ii:1211-4.
8. 2glycoprotein 1 antibody: specificity and clinical significance. Lupus 1996; 5:378-80.
9. Roubey RAS. Antigenic specifities of antiphospholipid autoantibodies: implications for clinical laboratory testing and diagnosis of the antiphospholipid syndrome. Lupus 1996; 5:425-30.
10. DeWolf F, Carreras LO, Moerman P, et al. Decidual vasculopathy and extensive placental infarction in a patient with thromboembolic accidents, recurrent fetal loss and a lupus anticoagulant. Am J Obstet Gynecol 1982; 142:829-34.
11. Lubbe WF, Palmer JJ, Butler WS, Liggins GC. Fetal survival after prednisone suppression of lupus anticoagulant. Lancet 1983; i:1361-3.
12. Branch DW, Scott JR, Kochenour NK, et al. Obstetric complications associated with lupus anticoagulant. New Eng J Med 1985; 313:1322-6.
13. Tincani A, Cattaneo R, Faden D, et al. Antiphospholipid antibodies in recurrent fetal loss: only one side of the coin. Clin Exp Rheumatol 1989; 7:390-1.
14. Ordi J, Barquinero J, Vilardell M, et al. Fetal loss treatment in patients with antiphospholipid antibodies. Ann Rheum Dis 1989; 48:798-802.
15. Branch DW, Silver RM, Blackwell JL, et al. Outcome of treated pregnancies in women with Antiphospholipid Syndrome: an update of the Utah experience. Obstet Gynecol 1992; 80:614-20.
16. Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989; 160:439-43.
17. Rosove MH, Tabsh K, Wasserstrum N, et al. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol 1990; 75:630-4.
18. Cowchock FS, Reece EA, Balaham D, et al. Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone to low-dose heparin treatment. Am J Obstet Gynecol 1992; 166:1318-27.
19. McVerry BA, Spearing R, Smith A. SLE anticoagulant: Transient inhibition by high dose immunoglobulin infusions. Br J Haematol 1985; 61:579-80.
20. Tchemia G, Dreyfus M, Laurian Y, et al. Management of immune thrombocytopenia in pregnancy: response to infusions of immunoglobulins. Am J Obstet Gynecol 1984; 148:225-6.
21. Sultan Y, Kazatckine MD, Maissonneuve P, et al. Anti-idiotypic suppression of autoantibodies to factor VIR by high dose intravenous immunoglobulin. Lancet 1984; ii:765-8.
22. Carreras LO, Perez GN, Vega HR, Casavilla F. Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin. Lancet 1988; 2:393-4.
23. Orvieto R, Achiron A, Ben-Rafael Z, Achiron R. Intravenous immunoglobulin treatment for recurrent abortions caused by antiphospholipid antibodies. Fertil Steril 1991; 56:1013-20.
24. Scott JR, Branch DW, Kochenour NK, Ward K. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization. Am J Obstet Gynecol 1989; 159:1055-6.
25. Parke A, Maier D, Wilson D, et al. Intravenous gamma-globulin antiphospholipid antibodies, and pregnancy. Ann Intern Med 1989; 110:495-6.
26. Wapner RJ, Cowchock FS, Shapiro SS. Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous gammaglobulin infusions. Am J Obstet Gynecol 1989; 616:1271-2.
27. Katz VL, Thorp JM, Watson WJ, et al. Human immunoglobulin therapy for preclampsia associated with high dose intravenous immunoglobulin. Obstet Gynecol 1990; 76:986-7.
28. Valensise H, Vaquero E, DeCarolis C, et al. Normal fetal growth in women with antiphospholipid syndrome treated with high-dose intravenous immunoglobulin. Prenat Diagn 1995; 15:509-17.
29. Spinnato JA, Clark AL, Pierangeli SS, Harris EN. Intravenous immunoglobulin therapy for antiphospholipid syndrome in pregnancy. Am J Obstet Gynecol 1995; 172:690-4.
30. Amout J, Spitz B, Wittervrongel C, et al. High dose intravenous immunoglobulin treatment of a pregnant patient with antiphospholipid syndrome: inununological changes associated with a successful outcome. Thromb Haemost 1994; 71:741-7.
31. Dwyer JM. Manipulating the immune system with immunoglobulin. New Engl J Med 1992; 326:107-6.
32. Bakimer R, Guilbard B, Zurgh N, Shoenfeld Y. The effect of intravenous gammaglobulin (IVIg) on the induction of experimental APS. Clin Immunol Immunopathol 1993; 69(1):97-102.
33. Clark AL, Gall SA. Clinical uses of intravenous immunoglobulin in pregnancy. Am J Obstet Gynecol 1997; 176:241-53.